1.618 Consulting assists large and small biopharmaceutical companies and other entities in assessing projects, portfolio and process and in developing strategies that maximize the desired outcomes while minimizing costs, time and risk.



1.618 Consulting brings together uncommon analyses, perspectives, and solutions to provide uncommon wisdom to ensure your success by focusing on the intersection of science, the regulatory environment and your commercial needs.



1.618 Consulting works collaboratively to explore the data, engage in debate, examine the assumptions and consider the intended and unintended outcomes in an iterative manner that allows for transparent decision-making and provides a structure to deal with future issues.